TOT BIOPHARM Self-Developed Biological Drug TAB008 (Pusintin) Meets Primary Endpoint in Phase III Clinical Trial

Written by ACN Newswire - Press Releases

HONG KONG, Apr 22, 2020 - (ACN Newswire) - TOT BIOPHARM International Company Limited ("TOT BIOPHARM" or the "Company"; stock code: 1875.HK) is pleased to announce that the randomized Phase III clinical trial of TAB008 (Pusintin) has recently reached the predefined primary endpoint. The Company will continue to push forward the new drug

Read more //?#

Why Your Business Needs Data Loss Prevention Software Today
In today’s data-driven world, businesses of all sizes face growing challenges in safeguarding sensitive information. Whethe…
Deciding Between Traditional and Headless CMS
Selecting a CMS impacts your organization's operations, web presence, and potential growth down the line. However, for your…
NSW is again cleaning up after major floods. Are we veering towards the collapse of insurability?
Once again, large parts of New South Wales have been devastated by floods. It’s estimated 10,000 homes and businesses m…
How Can Taking Insolvency Advice Minimise Damage from Company Debt?
While you can meticulously plan and manage your company’s finances, you can’t always anticipate the unexpected. If your com…
The Best AI Form Builders: A Balanced Guide to Smarter Data Collection
It feels like we hear about a new must-have AI tool daily. And with a crowded market full of innovative tools, choosing the r…
Behind the wellness industry’s scented oils and soothing music are often underpaid, exploited workers
Prostock Studio/ShutterstockWellness tourism is booming. Think yoga retreats in Bali, digital detox weekends in a rainforest…

Traditions of Rural Bali at Villa Sabana
A Privileged Insight into the Traditions of Rural Bali at Villa Sabana Situated in the traditional village of Pererenan near Canggu, Villa Sabana is peacefully secluded in a semi-rural setting where…

How Sydney Drone Photography Transforms the Way Properties Are Marketed
Key Highlights Drone photography provides stunning aerial perspectives, showcasing properties in a way that traditional photography cannot match. This innovative technology allows real estate agents to highlight property features, surrounding amenities, and…

inflation misses again, so where does the RBA go next?
Vital Signs is a regular economic wrap from UNSW economics professor Richard Holden (@profholden). Vital Signs aims to contextualise weekly economic events and cut through the noise of the data…
Virtual Reality and Its Impact On Business
The majority of people tend to relate Virtual Reality to headsets and gaming. But it’s much more than that. Virtual Reality is a potent technology that has significant business value…
Life Is Easier With King Single Bunk Beds
Buying a bed for your child’s bedroom can be a daunting task. You want something comfortable, sturdy and safe, but also has enough space to accommodate all of your belongings…

The quiet majority: why marketers need to cater to low intent shoppers

When shoppers are browsing online, whether for a new phone, holiday, or pair of shoes, they usually know exactly where they stand. Sometimes they’...

Lack of Salary Transparency is Costing Businesses Top Talent, Says Recruiters

As end-of-financial-year reviews approach, new research reveals a growing disconnect between Australian employers and employees on the issue of sa...

Sleep Soundly, Knowing Your People Are Paid Right: Navigating the Complexities of Modern Payroll

The Role of Modern Payroll Modern payroll systems are essential to any organization's financial infrastructure in today's rapidly evolving business...

Tariffs for dummies: Getting to grips with the business of exporting goods and services

It pays to understand how the international taxation system works before you start selling abroad. Take a glance at the business news just now an...

Deputy Unveils Enterprise-Grade Analytics+ to Power Smarter Workforce Decisions for Shift-Based Businesses

Deputy, the world’s leading workforce management platform for shift work, today announced the global launch of Deputy Analytics+, a next-generatio...

UNSW startup accelerator offers $200K to the next generation of Australian deeptech unicorns

UNSW Founders, Australia’s most recommended startup accelerator, has partnered with fund manager Luminary Partners to invest $200,000 each into 18...